Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Gerald E. Bisbee, Jr., PhD retired from the Board of Directors (the "Board") of
Cerner Corporation ("Cerner," the "Company" or "our"), effective immediately
prior to Cerner's 2022 Annual Meeting of Shareholders held on May 26, 2022 (the
"2022 Annual Meeting"). Immediately thereafter, the size of the Board was
decreased to nine members.

As reported below, at the 2022 Annual Meeting, Cerner's shareholders approved
the amendment and restatement of the Cerner Corporation 2011 Omnibus Equity
Incentive Plan (as amended and restated, the "Omnibus Plan"). A summary of the
Omnibus Plan is included in Proposal #5 of Cerner's definitive proxy statement
filed with the Securities and Exchange Commission on April 11, 2022 (the "2022
Proxy Statement"). The description below of the Omnibus Plan is qualified in its
entirety by reference to the full text of the plan filed herewith as Exhibit
10.1 and incorporated herein by reference.

Since 2011, the Omnibus Plan has provided an important incentive to (i) create
continued alignment of Cerner's vision and mission between eligible participants
and shareholders, (ii) attract, hire and retain quality associates in an
industry that has a very competitive market for talented employees, and (iii)
meet the Company's goal of establishing a broad-based, long-term ownership focus
for the Company's high performing associates. We believe that operation of the
Omnibus Plan is important in attracting, retaining and motivating key
associates, consultants, and non-employee Directors in a competitive labor
market, which is essential to our long-term growth and success. The terms of the
Omnibus Plan provide for the granting of stock options, stock appreciation
rights, restricted stock, restricted stock units, performance shares,
performance units, performance grants and bonus shares, some of which may be
paid in cash, shares of Cerner common stock, or a combination of cash and shares
of Cerner common stock. Eligible participants under the Omnibus Plan include key
associates, consultants and non-employee directors. The Omnibus Plan is
administered by the Compensation Committee (or such other committee as the Board
of Directors may determine), and such Compensation Committee has the sole
discretion to determine who may be granted awards under the Omnibus Plan, the
size and types of such awards and the terms and conditions of such awards.

The amendments to the Omnibus Plan:



•Increase the maximum number of shares of Cerner common stock authorized for
issuance under the Omnibus Plan by 5,000,000 shares. Subject to certain
adjustments, the maximum number of shares of Cerner common stock that may be
delivered pursuant to awards under the Omnibus Plan following the amendments is
the sum of 59,300,000 shares, plus (i) that number of Shares available for
issuance under the Cerner Corporation 2004 Long-Term Incentive Plan G (the "Plan
G") as of May 27, 2011, and (ii) that number of Shares subject to awards under
Plan G that were outstanding as of May 27, 2011 and that, on or after May 27,
2011, expire or are cancelled or terminated without the issuance of shares
thereunder.

•Extended the term of the Omnibus Plan to May 25, 2032.

--------------------------------------------------------------------------------

Item 5.07 Submission of Matters to a Vote of Security Holders.



At the 2022 Annual Meeting, Cerner's shareholders considered and voted on the
proposals described in detail in the 2022 Proxy Statement. The following is a
brief description of the matters that were voted on at the 2022 Annual Meeting
and the results of such voting:

Proposal No. 1 - The election of Mitchell E. Daniels, Jr., Elder Granger, M.D.,
John J. Greisch, Melinda J. Mount, George A. Riedel and R. Halsey Wise, each to
serve until the 2023 Annual Shareholders' Meeting, or until their respective
successors are duly elected and qualified.

Final Results: Mitchell E. Daniels, Jr., Elder Granger, M.D., John J. Greisch,
Melinda J. Mount, George A. Riedel and R. Halsey Wise were each elected as
Directors.

                                                                                                                                    Broker
                                               For                       Against                    Abstentions                   Non-votes

Mitchell E. Daniels, Jr.                     182,987,560                 30,069,480                   2,637,615                    35,794,035
Elder Granger, M.D.                          204,466,022                  8,884,084                   2,344,549                    35,794,035
John J. Greisch                              209,442,356                  3,860,958                   2,391,341                    35,794,035
Melinda J. Mount                             209,510,458                  3,803,687                   2,380,510                    35,794,035
George A. Riedel                             202,821,209                 10,380,790                   2,492,656                    35,794,035
R. Halsey Wise                               179,034,369                 34,161,172                   2,499,114                    35,794,035

Proposal No. 2 - The ratification of the appointment of KPMG LLP as the independent registered public accounting firm of Cerner for 2022.

Final Results: The shareholders ratified the appointment of KPMG LLP as our independent registered public accounting firm for 2022.



      For               Against           Abstentions

 234,682,303         14,682,002          2,124,385

There were no broker non-votes with respect to this proposal.

Proposal No. 3 - An advisory vote to approve the compensation of our Named Executive Officers.

Final Results: The shareholders approved, on an advisory basis, the compensation of our Named Executive Officers.



                                                                 Broker
      For               Against           Abstentions           Non-votes

 191,876,471         20,600,424          3,217,760            35,794,035






--------------------------------------------------------------------------------

Proposal No. 4 - The approval of the proposed amendments to our Third Restated
Certificate of Incorporation (as amended, the "Certificate") to remove the
supermajority voting standards. This proposal included four separate
subproposals, which were voted on separately; the approval of any of the
proposed amendments was not conditioned upon approval of the other proposed
amendments. The approval of each of these amendments requires the approval of
80% or more of the aggregate outstanding shares of the Company.

Proposal #4(a): The approval of the proposed amendments to our Certificate to remove the supermajority voting standards for certain business combination transactions with interested stockholders.



Final Results: The shareholders did not approve the proposed amendments to our
Certificate to remove the supermajority voting standards for certain business
combination transactions with interested stockholders.

                                                               Broker
      For              Against          Abstentions           Non-votes

 210,699,492        3,023,056          1,972,107            35,794,035



Proposal #4(b): The approval of the proposed amendments to our Certificate to
remove the supermajority voting standards to amend or repeal any provision of
the Bylaws.

Final Results: The shareholders did not approve the proposed amendments to our
Certificate to remove the supermajority voting standards to amend or repeal any
provision of the Bylaws.

                                                               Broker
      For              Against          Abstentions           Non-votes

 210,616,181        3,094,339          1,984,135            35,794,035



Proposal #4(c): The approval of the proposed amendments to our Certificate to
remove the supermajority voting standards to amend or repeal certain provisions
of the Certificate.

Final Results: The shareholders did not approve the proposed amendments to our Certificate to remove the supermajority voting standards to amend or repeal certain provisions of the Certificate.



                                                               Broker
      For              Against          Abstentions           Non-votes

 210,610,112        3,090,882          1,993,661            35,794,035

Proposal #4(d): The approval of the proposed amendments to our Certificate to remove the supermajority voting standards to remove a director with cause.



Final Results: The shareholders did not approve the proposed amendments to our
Certificate to remove the supermajority voting standards to remove a director
with cause.

                                                               Broker
      For              Against          Abstentions           Non-votes

 210,956,945        2,763,375          1,974,335            35,794,035






--------------------------------------------------------------------------------

Proposal No. 5 - The amendment and restatement of the Omnibus Plan to increase the number of authorized shares and extend the plan's term.



Final Results: The shareholders approved the amendment and restatement of the
Omnibus Plan to increase the number of authorized shares and extend the plan's
term.

                                                                 Broker
      For               Against           Abstentions           Non-votes

 198,746,024         14,693,428          2,255,203            35,794,035

Proposal No. 6 - The consideration of a shareholder proposal requesting an amendment to Cerner's governing documents to give shareholders the right to call a special shareholder meeting.



Final Results: The shareholder proposal requesting an amendment to the Company's
governing documents giving shareholders the right to call a special shareholder
meeting was approved.

                                                                 Broker
      For               Against           Abstentions           Non-votes

 158,061,172         54,528,885          3,104,598            35,794,035

Item 9.01 Financial Statements and Exhibits.



d) Exhibits

Exhibit
Number                  Description

10.1                      Cerner Corporation 2011 Omnibus Equity Incentive Plan (As Amended and
                        Restated May 26, 2022)

104                     Cover Page Interactive Data File (embedded within the Inline XBRL
                        document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses